Carlota de Miguel Barbero, Mercè Avellanet Viladomat, Elvira Gea Rodríguez, Francesc Garcia Cuyàs
{"title":"[基于iSYSCore和Tic Salut社会基金会评价方法的抗肿瘤药物不良反应注册监测移动应用描述性分析]","authors":"Carlota de Miguel Barbero, Mercè Avellanet Viladomat, Elvira Gea Rodríguez, Francesc Garcia Cuyàs","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The daily use of mobile healthcare applications is already a reality around the world. Their supply and demand forecasts continue to increase exponentially due to the multiple facilities and improvements that they can offer to health management and patient-centered care, especially for the chronically ill. However, this exponential growth in the offer confuses when choosing the best mobile application to use due to the lack of scientific evidence on whether they meet the safety criteria for patients and professionals. The objective of this work was to analyze mobile applications to record and monitor the adverse effects of Available Oral Antineoplastic Treatments, to have a guide on which of these applications could be recommended with certainty by health professionals to cancer patients.</p><p><strong>Methods: </strong>A search of mobile applications was carried out on the Android and iOS platforms in Spanish and English. Subsequently, each application is analyzed according to the accreditation criteria of the <i>iSYSCore</i> (Internet Health and Society) and the Tic Salut Social Foundation.</p><p><strong>Results: </strong>Twelve applications were found for monitoring the adverse effects of ANEOs, eight of which could be safely recommended by healthcare professionals where the scores of the Tic Salut Social Foundation range from 31 to 32 points out of 40 and those of <i>iSYSCore</i> from 31 to 36 points out of 47.</p><p><strong>Conclusions: </strong>The e-Onco Salud® application stands out for its ability to improve health management and empower patients in the management of their disease.</p>","PeriodicalId":47152,"journal":{"name":"Revista Espanola De Salud Publica","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2022-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Descriptive analysis of the mobile applications for registering and monitoring the adverse effects of antineoplastic drugs according to the evaluation methodology of <i>iSYSCore</i> and the Tic Salut Social Foundation.]\",\"authors\":\"Carlota de Miguel Barbero, Mercè Avellanet Viladomat, Elvira Gea Rodríguez, Francesc Garcia Cuyàs\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>The daily use of mobile healthcare applications is already a reality around the world. Their supply and demand forecasts continue to increase exponentially due to the multiple facilities and improvements that they can offer to health management and patient-centered care, especially for the chronically ill. However, this exponential growth in the offer confuses when choosing the best mobile application to use due to the lack of scientific evidence on whether they meet the safety criteria for patients and professionals. The objective of this work was to analyze mobile applications to record and monitor the adverse effects of Available Oral Antineoplastic Treatments, to have a guide on which of these applications could be recommended with certainty by health professionals to cancer patients.</p><p><strong>Methods: </strong>A search of mobile applications was carried out on the Android and iOS platforms in Spanish and English. Subsequently, each application is analyzed according to the accreditation criteria of the <i>iSYSCore</i> (Internet Health and Society) and the Tic Salut Social Foundation.</p><p><strong>Results: </strong>Twelve applications were found for monitoring the adverse effects of ANEOs, eight of which could be safely recommended by healthcare professionals where the scores of the Tic Salut Social Foundation range from 31 to 32 points out of 40 and those of <i>iSYSCore</i> from 31 to 36 points out of 47.</p><p><strong>Conclusions: </strong>The e-Onco Salud® application stands out for its ability to improve health management and empower patients in the management of their disease.</p>\",\"PeriodicalId\":47152,\"journal\":{\"name\":\"Revista Espanola De Salud Publica\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2022-01-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Espanola De Salud Publica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Espanola De Salud Publica","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
[Descriptive analysis of the mobile applications for registering and monitoring the adverse effects of antineoplastic drugs according to the evaluation methodology of iSYSCore and the Tic Salut Social Foundation.]
Objective: The daily use of mobile healthcare applications is already a reality around the world. Their supply and demand forecasts continue to increase exponentially due to the multiple facilities and improvements that they can offer to health management and patient-centered care, especially for the chronically ill. However, this exponential growth in the offer confuses when choosing the best mobile application to use due to the lack of scientific evidence on whether they meet the safety criteria for patients and professionals. The objective of this work was to analyze mobile applications to record and monitor the adverse effects of Available Oral Antineoplastic Treatments, to have a guide on which of these applications could be recommended with certainty by health professionals to cancer patients.
Methods: A search of mobile applications was carried out on the Android and iOS platforms in Spanish and English. Subsequently, each application is analyzed according to the accreditation criteria of the iSYSCore (Internet Health and Society) and the Tic Salut Social Foundation.
Results: Twelve applications were found for monitoring the adverse effects of ANEOs, eight of which could be safely recommended by healthcare professionals where the scores of the Tic Salut Social Foundation range from 31 to 32 points out of 40 and those of iSYSCore from 31 to 36 points out of 47.
Conclusions: The e-Onco Salud® application stands out for its ability to improve health management and empower patients in the management of their disease.